DiscGenics' first product candidate, an injectable disc cell therapy, or IDCT, is a homologous, allogeneic cell therapy that utilizes proprietary Discogenic Cells to offer a non-surgical ...

By Reuters April 26, 20181:09 PM UTCUpdated ago April 26 (Reuters) - DiscGenics Inc: * DISCGENICS ANNOUNCES FIRST PATIENT TREATED IN U.S. CLINICAL TRIAL OF IDCT FOR DEGENERATIVE DISC DISEASE ...